MetLife Investment Management, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$55,171
-11.2%
53,5640.0%0.00%
Q2 2023$62,134
-23.2%
53,5640.0%0.00%
-100.0%
Q1 2023$80,881
-39.6%
53,5640.0%0.00%0.0%
Q4 2022$133,910
-40.8%
53,5640.0%0.00%
-50.0%
Q3 2022$226,040
+51.3%
53,5640.0%0.00%
+100.0%
Q2 2022$149,444
-51.2%
53,5640.0%0.00%
-50.0%
Q1 2022$306,386
+2.4%
53,564
+63.4%
0.00%
-33.3%
Q4 2021$299,217
-14.6%
32,7730.0%0.00%0.0%
Q3 2021$350,343
-31.1%
32,7730.0%0.00%
-40.0%
Q2 2021$508,637
-4.3%
32,7730.0%0.01%0.0%
Q1 2021$531,250
-35.8%
32,773
-16.1%
0.01%
-37.5%
Q4 2020$827,001
+42.8%
39,0740.0%0.01%
+33.3%
Q3 2020$579,077
+0.7%
39,0740.0%0.01%
-14.3%
Q2 2020$574,779
+34.0%
39,074
+6.9%
0.01%
+16.7%
Q1 2020$429,027
-50.0%
36,5440.0%0.01%
-33.3%
Q4 2019$858,784
+37.2%
36,544
+8.0%
0.01%
+28.6%
Q3 2019$626,059
-0.5%
33,8410.0%0.01%0.0%
Q2 2019$629,103
-12.3%
33,841
+15.2%
0.01%
-12.5%
Q1 2019$717,705
-5.8%
29,3660.0%0.01%
-20.0%
Q4 2018$761,754
-18.0%
29,3660.0%0.01%0.0%
Q3 2018$929,434
-18.5%
29,3660.0%0.01%
-23.1%
Q2 2018$1,141,000
+65.6%
29,366
+17.6%
0.01%
+62.5%
Q1 2018$689,000
+72.7%
24,972
+13.3%
0.01%
+60.0%
Q4 2017$399,00022,0460.01%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders